−2.02USD
−23.52 MUSD
13.27 M
About enVVeno Medical Corporation
Sector
Industry
CEO
Robert Andrew Berman
Website
Headquarters
Irvine
Employees (FY)
31
Founded
1999
FIGI
BBG000PVDC20
enVVeno Medical Corp. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include VenoValve and enVVe. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NVNO is 5.22 USD — it has decreased by 5.09% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange enVVeno Medical Corporation stocks are traded under the ticker NVNO.
enVVeno Medical Corporation is going to release the next earnings report on Apr 29, 2024. Keep track of upcoming events with our Earnings Calendar.
NVNO stock is 11.33% volatile and has beta coefficient of 0.17. Check out the list of the most volatile stocks — is enVVeno Medical Corporation there?
NVNO earnings for the last quarter are −0.45 USD per share, whereas the estimation was −0.48 USD resulting in a 6.25% surprise. The estimated earnings for the next quarter are −0.24 USD per share. See more details about enVVeno Medical Corporation earnings.
enVVeno Medical Corporation revenue for the last quarter amounts to 31.00 K USD despite the estimated figure of 30.00 K USD. In the next quarter revenue is expected to reach 120.00 K USD.
Yes, you can track enVVeno Medical Corporation financials in yearly and quarterly reports right on TradingView.
NVNO stock has risen by 8.07% compared to the previous week, the month change is a 8.42% fall, over the last year enVVeno Medical Corporation has showed a 30.83% increase.
NVNO net income for the last quarter is −5.65 M USD, while the quarter before that showed −5.00 M USD of net income which accounts for −12.96% change. Track more enVVeno Medical Corporation financial stats to get the full picture.
Today enVVeno Medical Corporation has the market capitalization of 73.24 M, it has increased by 3.15% over the last week.
No, NVNO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NVNO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade enVVeno Medical Corporation stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 31.00 employees. See our rating of the largest employees — is enVVeno Medical Corporation on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So enVVeno Medical Corporation technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating enVVeno Medical Corporation stock shows the neutral signal. See more of enVVeno Medical Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on enVVeno Medical Corporation future price: according to them, NVNO price has a max estimate of 20.40 USD and a min estimate of 20.40 USD. Read a more detailed enVVeno Medical Corporation forecast: see what analysts think of enVVeno Medical Corporation and suggest that you do with its stocks.